Top 10 Scams
2017 Top 10 Consumer Complaints
File a Report
Thank You
Thank you for your submission. A member of the Attorney General's office will review and contact you with further details.
Contact Us
Consumer Protection Division Mediation Center:
Attorney General's Office
2115 State Capitol, Lincoln, NE 68509
ago.consumer@nebraska.gov
Mediation Center Phone:
(402) 471-2682 (local)
(800) 727-6432 (toll free)
(888) 850-7555 (En Español)
(888) 287-0778 (Senior)
For all other types of complaints please click here
Why Report Fraud
Reporting fraud can offer a wide range of benefits to Nebraskans.
About the Division
The Consumer Protection Division of the Attorney General’s Office protects Nebraskans from unfair, unconscionable and deceptive trade practices, ensures fair competition between businesses, and is responsible for oversight of charitable assets and entities. The Consumer Protection Division accomplishes this through: (1) consumer education, (2) mediation of consumer complaints, and (3) enforcement.
MoneyGram Settlement
Attorney General Doug Peterson today announced a settlement with Dallas based MoneyGram Payment Systems, Inc. resolving a multistate investigation which focused on complaints of consumers who used MoneyGram’s wire transfer service to send money to third parties involved in schemes to defraud consumers. In addition to Nebraska, 48 states and the District of Columbia participated in this settlement.
HSBC Settlement
Attorney General Doug Peterson today announced a $470 million joint state-federal settlement with mortgage lender and servicer HSBC to address mortgage origination, servicing, and foreclosure abuses.
The settlement provides direct payments to Nebraska borrowers for past foreclosure abuses, loan modifications and other relief for borrowers in need of assistance, rigorous mortgage servicing standards, and grants oversight authority to an independent monitor.
The settlement includes Nebraska and forty-eight other states, the District of Columbia, the U.S. Department of Justice (DOJ), the U.S. Department of Housing and Urban Development (HUD), and the Consumer Financial Protection Bureau (CFPB).
Compliance Violation Postcard
Attorney General Doug Peterson is issuing an alert for Nebraskans to be wary of a postcard being sent to Nebraska companies. Several businesses have reported receiving the official-looking postcard purporting to be from “United Business Services Compliance Division” providing a “Notice of Potential Compliance Violation” and listing a phone number to call immediately to avoid fees and penalties.
This is a scam. The mailing appears to be an official government document, but it is not. Currently, there is not an entity registered to do business in Nebraska by the name of “United Business Services.” The address used by this questionable entity is that of a downtown apartment complex. We believe the scammers are preying on newly registered limited liability companies, who may not know what rules they actually need to follow.
Recipients of the postcard have reported that when calling the number provided they are directed to pay a one-time fee of roughly $70 to apply for a Certificate of Good Standing or to pay for a similar service that is not necessarily needed. Official, correct certificates may be requested from the Secretary of State’s office online or by mail.
Novartis Pharmaceuticals Settlement
Attorney General Doug Peterson announced today that the State of Nebraska reached an agreement in principle to settle kickback claims against Novartis Pharmaceuticals Corporation. The settlement will resolve allegations that Novartis provided kickbacks to certain specialty pharmacies in exchange for recommending the drug Exjade to Medicaid and Medicare patients. Under the settlement, Novartis has agreed to pay $390 million to the United States and over 40 states. Nebraska will receive more than $420,000 under the settlement.
Novartis manufactures Exjade which was approved by the U.S. Food and Drug Administration for the treatment of chronic iron overload due to blood transfusions. After launching the drug, Novartis marketed Exjade as a treatment for patients with a number of underlying conditions that affect blood cells or bone marrow, such as sickle cell disease
